Literature DB >> 10408288

Non-traumatic colorectal perforations.

T Yilmazlar1, S Toker, A Zorluoğlu.   

Abstract

Over a 6 year period, between January 1992 and December 1997, 30 patients with non-traumatic colorectal perforations undergoing laparotomy were reviewed. The aim of this study was to evaluate predictions on the prognosis using the Mannheim Peritonitis Index (MPI) and to evaluate the risk of this complication. The mean age of the patients was 56.4 years (range 16-88 years). The male:female ratio was 19:11. All patients showed signs of peritonitis and underwent emergency operations. In 50% (15) of the patients, tumor was the cause. According to the MPI scoring, there were 18 patients with an MPI score of 26 or less and 12 patients with an MPI score of 27 or more. For patients with a score less than 27 the mortality rate was zero (0/18) and for score greater than 26, 66.6% (8/12). Overall mortality was 26.6% (8/30). Of 15 patients with perforated colorectal cancers, four patients died (26.6%). The mortality rate for benign perforations was 26.6% (4/15) also. In conclusion, colorectal cancers are the most common cause of the non-traumatic colorectal perforations. Patients with an MPI score greater than 26 represent the highest risk group.

Entities:  

Mesh:

Year:  1999        PMID: 10408288

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  2 in total

1.  Coagulation disorder as a prognostic factor for patients with colorectal perforation.

Authors:  Kazushige Kawai; Takeyuki Hiramatsu; Ryo Kobayashi; Naoki Takabayashi; Yukio Ishihara; Ko Ohata; Hirotaka Niwa; Junji Yasuike; Hiroki Tanaka; Mitsutoshi Kimura; Junichi Shindoh
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 6.772

2.  Low psoas muscle index is a poor prognostic factor for lower gastrointestinal perforation: a single-center retrospective cohort study.

Authors:  Hajime Kayano; Eiji Nomura; Rin Abe; Yasuhiko Ueda; Takashi Machida; Chikara Fujita; Shohei Uchiyama; Kazuyuki Endo; Katsuki Murakami; Masaya Mukai; Hiroyasu Makuuchi
Journal:  BMC Surg       Date:  2019-11-28       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.